Cassava (SAVA) Sees Share Surge Following Strategic Announcement
Following a recent strategic announcement, Cassava Sciences, Inc. (NASDAQ: SAVA) is experiencing a significant uptick in its stock performance. As of the latest market update, SAVA shares are trading at $20.72, marking an increase of 17.93%. Extension of Open-Label Trials Cassava Sciences (SAVA) has disclosed that it intends extending its open-label extension studies for its […]
Cassava Sciences, Inc. (SAVA) Stock Prices on the Rise After Success of Clinical Trials
Cassava Sciences, Inc. (SAVA) stock prices were up 5.61% as of market close on April 26th 2021, bringing the price per share up to USD$41.81 at the end of the trading day. Subsequent current market fluctuations saw the stock price climb 3.78% to it USD$43.39. SAVA’s Net Loss In their recently disclosed financial reports for […]
The Rally Continued For Cassava Sciences (SAVA), Up 43% Pre-Market
The biotechnology company, Cassava Sciences Inc. (SAVA), a developer of drugs for nervous system disorders, has been seeing its stock price rising 43.83% in early trades floating at $126.50 (07:12 a.m. EST). The rise could be attributed to results announced by the company on Tuesday of an interim analysis from an open-label study of the […]
